Although further work will be required to define the molecular pathways underlying the protective effects of RIOK1 and pelle knockdown, our findings raise the possibility that coordinate therapeutic targeting of the oxidative stress and immune signaling pathways may be beneficial in complex I deficiency patients. Here, IRAK1 is linked to hyperinsulinemic hypoglycemia, familial, 4.